Cingulate Inc. — Investor Relations & Filings
Filings indexed
445
across all filing types
Latest filing
2024-01-12
Registration Form
Country
US
United States of America
Listing
US
CING
Cingulate Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety. The company utilizes its proprietary Precision Timed Release (PTR) drug delivery platform, a novel erosion-based technology, to create medications with a true once-daily dosing profile. This platform is designed to provide controlled drug release for entire active-day efficacy. Cingulate's pipeline includes product candidates CTX-1301 and CTX-1302 for the ADHD market, and CTX-2103 for the anxiety market.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Registration Form 2024 | 2024-01-12 | English | |
| Major Shareholding Notification 2024 | 2024-01-04 | English | |
| Major Shareholding Notification 2024 | 2024-01-04 | English | |
| Director's Dealing 2024 | 2024-01-03 | English | |
| Regulatory Filings 2023 | 2023-12-28 | English | |
| Regulatory Filings 2023 | 2023-12-15 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
4 filings
| |||||
| 13458203 | Registration Form 2024 | 2024-01-12 | English | ||
| 13458205 | Major Shareholding Notification 2024 | 2024-01-04 | English | ||
| 13458204 | Major Shareholding Notification 2024 | 2024-01-04 | English | ||
| 13458206 | Director's Dealing 2024 | 2024-01-03 | English | ||
|
2023
11 filings
| |||||
| 13458207 | Regulatory Filings 2023 | 2023-12-28 | English | ||
| 13458208 | Regulatory Filings 2023 | 2023-12-15 | English | ||
| 13458209 | Regulatory Filings 2023 | 2023-12-12 | English | ||
| 13458210 | Regulatory Filings 2023 | 2023-12-06 | English | ||
| 13458212 | Regulatory Filings 2023 | 2023-11-28 | English | ||
| 13458211 | Registration Form 2023 | 2023-11-15 | English | ||
| 13458216 | Regulatory Filings 2023 | 2023-11-14 | English | ||
| 13458218 | Interim / Quarterly Report 2023 | 2023-11-13 | English | ||
| 13458213 | Regulatory Filings 2023 | 2023-11-13 | English | ||
| 13458214 | Major Shareholding Notification 2023 | 2023-11-08 | English | ||
| 13458215 | Regulatory Filings 2023 | 2023-11-03 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Cingulate Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34936/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34936 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34936 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34936 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34936}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Cingulate Inc. (id: 34936)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.